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Neuropsychiatric Disease and Treatment
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Kamijima K, Hashimoto S, Nagayoshi E, Koyama T. Neuropsychiatric Disease and Treatment. 2013; 9:555-565. On page 559, right column, line 10 from the bottom: (0.9 to 1.2) should read (−0.9 to 1.2). 
